The dietary management of sodium in children with kidney diseases—clinical practice recommendations from the Pediatric Renal Nutrition Taskforce José Renken-Terhaerdt, An Desloovere, Michiel JS Oosterveld, Nonnie Polderman, Evelien Snauwaert, Stella Stabouli, Johan Vande Walle, Caroline Anderson, Sheridan Collins, Larry A. Greenbaum, Matthew Harmer, Lyndsay Harshman, Christina L. Nelms, Pearl Pugh, Vanessa Shaw, Jetta Tuokkola, Molly R. Wong Vega, Bradley A. Warady, Rukshana Shroff, Fabio Paglialonga Pediatric Nephrology, 2026 Sodium imbalance is a common concern in children with kidney diseases, presenting as either sodium excess or sodium deficit, each with significant clinical implications. Sodium excess contributes to fluid overload and hypertension, while increased sodium losses, particularly via urine or peritoneal fluid, can predispose patients to hypotension and growth failure. Effective sodium management is thus a critical component of care in pediatric kidney diseases, with dietary sodium intake playing a pivotal role in maintaining homeostasis. The Pediatric Renal Nutrition Taskforce (PRNT) has developed clinical practice recommendations (CPRs) for dietary sodium management in children with kidney diseases, addressing key aspects of sodium balance, including primary dietary sources, nutritional assessment of sodium intake, non-dietary factors influencing sodium balance, and recommended intakes. Strategies for reducing sodium intake in cases of sodium excess and augmenting intake in patients with increased sodium losses are also provided. The consensus of international experts was assessed through a Delphi process. These CPRs will be regularly updated by the PRNT.
Ten tips on how to optimize nutrition in children with chronic kidney disease or on dialysis Nonnie Polderman, Vanessa Shaw, Caroline E Anderson, An Desloovere, Louise McAlister, Christina L Nelms, Fabio Paglialonga, Pearl Pugh, Leila Qizalbash, Evelien Snauwaert, José Renken-Terhaerdt, Jetta Tuokkola, Larry A Greenbaum, Rukshana Shroff Clinical Kidney Journal, 2026 Optimal nutrition is central to growth and development in all children, and is particularly relevant in those with chronic illnesses. This document provides 10 practical, evidence-informed tips on the assessment and management of the nutritional prescription in children with chronic kidney disease (CKD) and those receiving dialysis. The 10 tips synthesize work of the Paediatric Renal Nutrition Taskforce, an international team of pediatric renal dietitians and pediatric nephrologists who develop clinical practice recommendations for the nutritional management of children with kidney diseases. We describe a comprehensive, three-dimensional nutritional assessment (anthropometry, dietary intake, biochemical markers) and regular monitoring tailored to age, CKD stage and treatment modality. Energy prescriptions should approximate requirements of healthy peers, adjusting toward the upper end of the suggested dietary intake (SDI) for faltering growth, and accounting for dialysate-derived glucose in peritoneal dialysis (PD). Protein targets should align with the SDI, avoiding restriction to prevent impaired linear growth and protein-energy wasting; higher intakes are needed in children on PD to replace dialysate protein losses. Early, proactive strategies should address feeding barriers through fortification, oral supplements, timely initiation of enteral tube feeding and planning for gastrostomy insertion in patients on PD. A diet emphasizing fiber-rich, nutrient-dense foods is recommended, with individualized management of calcium, phosphate, potassium and sodium, and targeted micronutrient monitoring and supplementation. Reducing ultra-processed foods supports improved diet quality and mitigates cardiometabolic risk. Multidisciplinary care and ongoing outcome-focused research remain essential to refine nutritional targets and delivery approaches that optimize growth and long-term health in pediatric CKD.
Comparing outcomes with different dialysis modalities in children with kidney failure: home hemodialysis versus in-center hemodiafiltration or conventional hemodialysis Charlotte Ahlmann, Iona Madden, Andreas Busjahn, Olga Panagiotopoulou, Karolis Azukaitis, Sevcan A. Bakkaloglu, Ayşe Ağbaş, Ali Anarat, Varvara Askiti, Aysun K. Bayazit, Ipek Kaplan Bulut, Nur Canpolat, Dagmara Borzych-Duzalka, Ali Duzova, Sandra Habbig, Saoussen Krid, Christoph Licht, Mieczyslaw Litwin, Lukasz Obrycki, Fabio Paglialonga, Bruno Ranchin, Charlotte Samaille, Mohan Shenoy, Manish D. Sinha, Brankica Spasojevic, Lynsey Stronach, Enrico Vidal, Alev Yilmaz, Michel Fischbach, Franz Schaefer, Claus Peter Schmitt, Jun Oh, Daljit Hothi, Rukshana Shroff Pediatric Nephrology, 2026
Hospital readmission in children on maintenance dialysis: a multicentre, prospective cohort study Yeşim Özdemir Atikel, Eszter Lévai, Claus Peter Schmitt, Shazia Adalat, Nadine Goodman, Ayşe Seda Pınarbaşı, İsmail Dursun, Burcu Yazıcıoğlu, Fabio Paglialonga, Karel Vondrak, Isabella Guzzo, Nikoleta Printza, Ilona Zagożdżon, Aleksandra Zurowska, Bahriye Atmış, Aysun Karabay Bayazıt, Marcin Tkaczyk, Maria do Sameiro Faria, Ariane Zaloszyc, Augustina Jankauskiene, Mesiha Ekim, Alberto Edefonti, Rukshana Shroff, Sevcan A Bakkaloğlu Clinical Kidney Journal, 2026 Background Limited data exist on rehospitalization in paediatric dialysis patients. The objective of this study was to identify indications, rates and risk factors for 30-day readmissions in this population. Methods We used a prospective multinational, multicentre cohort study of haemodialysis (HD) and peritoneal dialysis (PD) patients discharged between July 2017 and July 2018. Readmission was identified as repeat hospitalization within 30 days of a prior (index) admission. Potentially preventable readmissions were clinically related to the initial admission. Early readmissions were those occurring within 7 days of discharge. The primary outcome was 30-day readmission. Secondary outcomes included potentially avoidable and early readmissions. Results A total of 54 (31%) of 176 patients (102 PD, 74 HD) had at least one readmission; 84 (18%) discharges were followed by readmission. PD and HD patients had similar readmission rates {30.4% versus 31.1%; hazard ratio [HR] 1.06 [95% confidence interval (CI) 0.61–1.81]}. Compared with PD, HD patients had a significantly shorter time to readmission (8 versus 14 days; P = .019), higher early readmission rates (46% versus 18%; P = .010) and risk [odds ratio (OR) 3.87 (95% CI 1.35–11.11)]. Main readmission causes were dialysis access–related non-infectious complications (31%) and access infections (22.7%); 47% of readmissions were potentially avoidable. Lower haemoglobin levels were linked to readmission [HR 0.78 (95% CI 0.64–0.95)]. Bicarbonate use was associated with a 51% lower readmission risk [HR 0.49 (95% CI 0.24–0.99)]. Neurological comorbidity [OR 7.00 (95% CI 1.04–47.22)] and partial recovery [OR 56.45 (95% CI 3.02–1053.10)] were risk factors for avoidable readmission. Risk of avoidable and early readmission decreased with age [OR 0.98 (95% CI 0.97–0.99) and OR 0.99(95%CI 0.98–0.99), respectively]. Conclusions Readmissions are common in paediatric dialysis patients, with a substantial proportion being potentially preventable. To reduce rehospitalizations, interventions should target modifiable factors such as access complications, anaemia and incomplete recovery at discharge, while recognizing non-modifiable risks like HD and younger age to identify high-risk patients.
Predicting mortality and short-term outcomes of continuous kidney replacement therapies in neonates and infants Anna Deja, Kamil Deja, Andrea Cappoli, Raffaella Labbadia, Rute Baeta Baptista, Zainab Arslan, Jun Oh, Aysun Karabay Bayazit, Dincer Yildizdas, Claus Peter Schmitt, Marcin Tkaczyk, Mirjana Cvetkovic, Mirjana Kostic, Augustina Jankauskiene, Ernestas Virsilas, Germana Longo, Enrico Vidal, Sevgi Mir, Ipek Kaplan Bulut, Andrea Pasini, Fabio Paglialonga, Giovanni Montini, Ebru Yilmaz, Liane Correia-Costa, Ana Teixeira, Franz Schaefer, Isabella Guzzo Nephrology Dialysis Transplantation, 2026 Background Continuous kidney replacement therapy (CKRT) has emerged as a valuable treatment option in critically ill neonates and infants with acute kidney injury (AKI) requiring dialysis. In this population, we apply artificial intelligence (AI) to identify factors influencing mortality and short-term adverse kidney outcomes. Methods The study involved neonates and infants included in the EurAKId Registry (NCT 02960867), who underwent CKRT treatment. Using the AI XGBoost models, we identified key clinical factors associated with short-term outcomes: mortality before hospital discharge, as well as proteinuria at discharge. We considered the patients’ clinical characteristics, anthropometric features, and CKRT technical settings. Results The study comprised 95 patients: 31.6% neonates and 68.4% infants with a median age at hospital admission of 1 month (interquartile range, IQR 0–7 months). Ten children were born prematurely. The overall mortality rate was 47.3% and did not differ significantly between neonates and infants (53.3% vs 44.4%, respectively, P = .422). The XGBoost model for predicting mortality had the accuracy of 59.53% ± 0.96% and AUC of 0.64 ± 0.11. Lower urine output at CKRT initiation, a greater rise in serum creatinine (SCr), longer time to dialysis initiation, and lower blood pressure were associated with increased risk of mortality. Proteinuria at hospital discharge was present in 30.6% of survivors. The XGBoost model for predicting proteinuria had the accuracy of 79.11% ± 2.46% and AUC (0.74 ± 0.04). Higher SCr concentrations at hospital admission and at CKRT start, as well as primary kidney disease were the most important risk factors for proteinuria. Conclusion We propose the XGBoost models for identifying factors associated with short-term outcomes of CKRT in neonates and infants. Lower urine output at CKRT start, more severe AKI progression and longer time to CKRT initiation might be important risk factors for mortality in infants and neonates. Primary kidney disease and related biochemical parameters are strong predictors of proteinuria at hospital discharge.
CytoSorb haemoadsorption in critically ill children: a multicentre observational study on feasibility, safety, and outcomes, the CYTOPED study Gabriella Bottari, Stefania Bianzina, Anna Tessari, Monica Fae, Sara Giovannini, Stefano Scollo, Elena Caporossi, Fabio Paglialonga, Pietro Lonardi, Raffaella Sagredini, Alessandro Simonini, Fabio Caramelli, Germana Longo, Corrado Cecchetti, Andrea Moscatelli, Isabella Guzzo Annals of Intensive Care, 2026 Introduction: CytoSorb® is a cartridge for the adsorption of inflammatory mediators, bilirubin, myoglobin and other xenobiotics, directly from the blood stream. Clinical experience is widely documented in adults, whereas, in the paediatric settings, it is currently limited to single case reports or monocentric studies. In order to be able to collect evidence in larger paediatric populations, an Italian multicentre network (CYTOPED study group) was founded. Methods: Italian multicentric observational registry on the use of CytoSorb® in critically ill paediatric patients. Prospective enrolment by Italian Children's Hospitals has been ongoing since February 2021 with a retrospective analysis conducted from February 2018 to February 2021. Results: = 36), followed by liver failure, rhabdomyolysis, cardiac surgery. CytoSorb® has been applied in 87% of cases integrated in a continuous renal replacement therapy (CRRT) circuit. The median time of HA was 48 h (IQR 26;72) and the median number of cartridges used was 2 (IQR 1;3). Anticoagulation in the extracorporeal circuit has been managed with heparin (76%) and regional citrate anticoagulation (24%). Adverse events were recorded in 12 patients. Conclusion: Our data provide some insights into safety and feasibility of CytoSorb® therapy in children. The advancement of the study and the prospective arm of CYTOPED registry will allow further investigation into this therapy, including dosage, timing and use of antibiotics in conjunction with extracorporeal blood purification techniques.
Assessment and management of magnesium and trace element status in children with CKD stages 2–5, on dialysis and post-transplantation: Clinical practice points from the Pediatric Renal Nutrition Taskforce Jetta Tuokkola, Caroline E. Anderson, Sheridan Collins, Pearl Pugh, Molly R. Wong Vega, Matthew Harmer, Lyndsay A. Harshman, Christina L. Nelms, Barry Toole, An Desloovere, Fabio Paglialonga, Nonnie Polderman, José Renken-Terhaerdt, Rukshana Shroff, Evelien Snauwaert, Stella Stabouli, Johan Vande Walle, Bradley A. Warady, Vanessa Shaw, Larry A. Greenbaum Pediatric Nephrology, 2025 Children and young people with chronic kidney disease (CKD) are at risk for deficiency or excess of magnesium and trace elements. Kidney function, dialysis, medication, and dietary and supplemental intake can affect their biochemical status. There is much uncertainty about the requirements of magnesium and trace elements in CKD, which leads to variation in practice. The Pediatric Renal Nutrition Taskforce is an international team of pediatric kidney dietitians and pediatric nephrologists, formed to develop evidence-based clinical practice points to improve the nutritional care of children with CKD. PICO (patient, intervention, comparator, and outcomes) questions led the literature searches, which were conducted to ascertain current biochemical status, dietary intake, and factors leading to requirements differing from healthy peers, and to guide nutritional care of children with CKD stages 2–5, on dialysis, and post-transplantation. We address the assessment and intervention of magnesium and the trace elements chromium, copper, fluoride, iodine, manganese, selenium, and zinc. We suggest routine biochemical assessment of magnesium. Trace element assessment is based on clinical suspicion of deficiency or excess and their risk factors, including accumulation, losses, medications, nutrient interactions, and comorbidities. In particular, we suggest assessing magnesium, copper, iodine, and zinc when growth is poor, and evaluating magnesium, copper, selenium, and zinc in the presence of proteinuria. A structured approach to magnesium and trace element management, including biochemical, physical, and dietary assessment, is beneficial in the paucity of evidence. Research recommendations are suggested.
Nutritional management of the child with chronic kidney disease and on dialysis Vanessa Shaw, Caroline Anderson, An Desloovere, Larry A. Greenbaum, Lyndsay Harshman, Christina L. Nelms, Pearl Pugh, Nonnie Polderman, José Renken-Terhaerdt, Evelien Snauwaert, Stella Stabouli, Jetta Tuokkola, Johan Vande Walle, Bradley A. Warady, Fabio Paglialonga, Rukshana Shroff Pediatric Nephrology, 2025
Factors influencing circuit lifetime in paediatric continuous kidney replacement therapies – results from the EurAKId registry Anna Deja, Isabella Guzzo, Andrea Cappoli, Raffaella Labbadia, Aysun Karabay Bayazit, Dincer Yildizdas, Claus Peter Schmitt, Marcin Tkaczyk, Mirjana Cvetkovic, Mirjana Kostic, Wesley Hayes, Rukshana Shroff, Augustina Jankauskiene, Ernestas Virsilas, Germana Longo, Enrico Vidal, Sevgi Mir, Ipek Kaplan Bulut, Andrea Pasini, Fabio Paglialonga, Giovanni Montini, Ebru Yilmaz, Liane Correia Costa, Ana Teixeira, Franz Schaefer, and Pediatric Nephrology, 2024
Changes in the cardiovascular risk profile in children approaching kidney replacement therapy Priyanka Khandelwal, Jonas Hofstetter, Karolis Azukaitis, Aysun Bayazit, Anke Doyon, Ali Duzova, Nur Canpolat, Ipek Kaplan Bulut, Lukasz Obryck, Bruno Ranchin, Dusan Paripovic, Sevcan Bakkaloglu, Harika Alpay, Klaus Arbeiter, Mieczyslaw Litwin, Ariane Zaloszyc, Fabio Paglialonga, Dagmara Borzych-Dużałka, Claus Peter Schmitt, Anette Melk, Uwe Querfeld, Franz Schaefer, Rukshana Shroff Eclinicalmedicine, 2024
Sodium intake and urinary losses in children on dialysis: a European multicenter prospective study Fabio Paglialonga, Rukshana Shroff, Ilona Zagozdzon, Sevcan A. Bakkaloglu, Ariane Zaloszyc, Augustina Jankauskiene, Alejandro Cruz Gual, Silvia Consolo, Maria Rosa Grassi, Louise McAlister, Aleksandra Skibiak, Burcu Yazicioglu, Giuseppe Puccio, Alberto Edefonti, Gema Ariceta, Christoph Aufricht, Tuula Holtta, Guenter Klaus, Bruno Ranchin, Claus Peter Schmitt, Evelien Snauwaert, Costantinos Stefanidis, Johan Vande Walle, Stella Stabouli, Enrico Verrina, Enrico Vidal, Karel Vondrak, Alexandra Zurowska, and Pediatric Nephrology, 2023
Nutritional management of the infant with chronic kidney disease stages 2–5 and on dialysis Vanessa Shaw, Caroline Anderson, An Desloovere, Larry A. Greenbaum, Dieter Haffner, Christina L. Nelms, Fabio Paglialonga, Nonnie Polderman, Leila Qizalbash, José Renken-Terhaerdt, Stella Stabouli, Jetta Tuokkola, Johan Vande Walle, Bradley A. Warady, Rukshana Shroff Pediatric Nephrology, 2023
Nutritional and Anthropometric Indices in Children Receiving Haemodiafiltration vs Conventional Haemodialysis - The HDF, Heart and Height (3H) Study Fabio Paglialonga, Alice Monzani, Flavia Prodam, Colette Smith, Francesca De Zan, Nur Canpolat, Ayse Agbas, Aysun Bayazit, Ali Anarat, Sevcan A. Bakkaloglu, Varvara Askiti, Constantinos J. Stefanidis, Karolis Azukaitis, Ipek Kaplan Bulut, Dagmara Borzych-Dużałka, Ali Duzova, Sandra Habbig, Saoussen Krid, Christoph Licht, Mieczyslaw Litwin, Lukasz Obrycki, Bruno Ranchin, Charlotte Samaille, Mohan Shenoy, Manish D. Sinha, Brankica Spasojevic, Enrico Vidal, Alev Yilmaz, Michel Fischbach, Franz Schaefer, Claus Peter Schmitt, Alberto Edefonti, Rukshana Shroff Journal of Renal Nutrition, 2023
Acute paediatric kidney replacement therapies in Europe: Demographic results from the EurAKId Registry Isabella Guzzo, Lara de Galasso, Aysun Karabay Bayazit, Dincer Yildizdas, Claus Peter Schmitt, Wesley Hayes, Rukshana Shroff, Augustina Jankauskiene, Ernestas Virsilas, Germana Longo, Enrico Vidal, Sevgi Mir, Ipek Kaplan Bulut, Marcin Tkaczyk, Francesca Mencarelli, Cristina Bertulli, Mrjana Cvetkovic, Mirjana Kostic, Fabio Paglialonga, Giovanni Montini, Ebru Yilmaz, Ana Teixeira, Bahriye Atmis, Franz Schaefer Nephrology Dialysis Transplantation, 2022
Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study Dagmar-Christiane Fischer, Colette Smith, Francesca De Zan, Justine Bacchetta, Sevcan A. Bakkaloglu, Ayse Agbas, Ali Anarat, Bilal Aoun, Varvara Askiti, Karolis Azukaitis, Aysun Bayazit, Ipek Kaplan Bulut, Nur Canpolat, Dagmara Borzych-Dużałka, Ali Duzova, Sandra Habbig, Saoussen Krid, Christoph Licht, Mieczyslaw Litwin, Lukasz Obrycki, Fabio Paglialonga, Anja Rahn, Bruno Ranchin, Charlotte Samaille, Mohan Shenoy, Manish D. Sinha, Brankica Spasojevic, Constantinos J. Stefanidis, Enrico Vidal, Alev Yilmaz, Michel Fischbach, Franz Schaefer, Claus Peter Schmitt, Rukshana Shroff Kidney International Reports, 2021
Hemodiafiltration maintains a sustained improvement in blood pressure compared to conventional hemodialysis in children—the HDF, heart and height (3H) study Francesca De Zan, Colette Smith, Ali Duzova, Aysun Bayazit, Constantinos J Stefanidis, Varvara Askiti, Karolis Azukaitis, Nur Canpolat, Ayse Agbas, Ali Anarat, Bilal Aoun, Sevcan A. Bakkaloglu, Dagmara Borzych-Dużałka, Ipek Kaplan Bulut, Sandra Habbig, Saoussen Krid, Christoph Licht, Mieczyslaw Litwin, Lukasz Obrycki, Fabio Paglialonga, Bruno Ranchin, Charlotte Samaille, Mohan Shenoy, Manish D Sinha, Brankica Spasojevic, Alev Yilmaz, Michel Fischbach, Claus Peter Schmitt, Franz Schaefer, Enrico Vidal, Rukshana Shroff Pediatric Nephrology, 2021
Rapid response in the COVID-19 pandemic: a Delphi study from the European Pediatric Dialysis Working Group On behalf of the European Pediatric Dialysis Working Group, Fabian Eibensteiner, Valentin Ritschl, Gema Ariceta, Augustina Jankauskiene, Günter Klaus, Fabio Paglialonga, Alberto Edefonti, Bruno Ranchin, Claus Peter Schmitt, Rukshana Shroff, Constantinos J. Stefanidis, Johan Vande Walle, Enrico Verrina, Karel Vondrak, Aleksandra Zurowska, Tanja Stamm, Christoph Aufricht Pediatric Nephrology, 2020
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Jennifer E. Flythe, Tara I. Chang, Martin P. Gallagher, Elizabeth Lindley, Magdalena Madero, Pantelis A. Sarafidis, Mark L. Unruh, Angela Yee-Moon Wang, Daniel E. Weiner, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, Kevan R. Polkinghorne, Teresa Adragão, Samaya J. Anumudu, Christopher T. Chan, Alfred K. Cheung, Maria Rosa Costanzo, Indranil Dasgupta, Andrew Davenport, Simon J. Davies, Marijke J.E. Dekker, Laura M. Dember, Daniel Gallego, Rafael Gómez, Carmel M. Hawley, Manfred Hecking, Kunitoshi Iseki, Vivekanand Jha, Jeroen P. Kooman, Csaba P. Kovesdy, Eduardo Lacson, Adrian Liew, Charmaine E. Lok, Christopher W. McIntyre, Rajnish Mehrotra, Dana C. Miskulin, Ezio Movilli, Fabio Paglialonga, Roberto Pecoits-Filho, Jeff Perl, Carol A. Pollock, Miguel C. Riella, Patrick Rossignol, Rukshana Shroff, Laura Solá, Henning Søndergaard, Sydney C.W. Tang, Allison Tong, Yusuke Tsukamoto, Suzanne Watnick, Matthew R. Weir, James B. Wetmore, Caroline Wilkie, Martin Wilkie Kidney International, 2020
Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population Evelien Snauwaert, Wim Van Biesen, Ann Raes, Griet Glorieux, Johan Vande Walle, Sanne Roels, Raymond Vanholder, Varvara Askiti, Karolis Azukaitis, Aysun Bayazit, Nur Canpolat, Michel Fischbach, Krid Saoussen, Mieczyslaw Litwin, Lukasz Obrycki, Fabio Paglialonga, Bruno Ranchin, Charlotte Samaille, Franz Schaefer, Claus Peter Schmitt, Brankica Spasojevic, Constantinos J Stefanidis, Rukshana Shroff, Sunny Eloot Nephrology Dialysis Transplantation, 2020
Genetic analyses in dent disease and characterization of CLCN5 mutations in kidney biopsies Lisa Gianesello, Monica Ceol, Loris Bertoldi, Liliana Terrin, Giovanna Priante, Luisa Murer, Licia Peruzzi, Mario Giordano, Fabio Paglialonga, Vincenzo Cantaluppi, Claudio Musetti, Giorgio Valle, Dorella Del Prete, Franca Anglani, Dent Disease Italian Network International Journal of Molecular Sciences, 2020
Vascular access in children requiring maintenance haemodialysis: A consensus document by the European Society for Paediatric Nephrology Dialysis Working Group Rukshana Shroff, Francis Calder, Sevcan Bakkaloğlu, Evi V Nagler, Sam Stuart, Lynsey Stronach, Claus P Schmitt, Karl H Heckert, Pierre Bourquelot, Ann-Marie Wagner, Fabio Paglialonga, Sandip Mitra, Constantinos J Stefanidis, European Society for Paediatric Nephrology Dialysis Working Group, C Aufricht, J Van de Walle, K Vondrak, T Holtta, B Ranchin, A Zaloszyc, S Krid, C Pietrement, C P Schmitt, G Klaus, D Muller, J Thumfart, C Stefanidis, N Printza, S Stabouli, A Edefonti, F Paglialonga, L Peruzzi, E Verrina, E Vidal, M Allinovi, I Guzzo, A Jankauskiene, A Zurowska, M Tkaczyk, M Do Sameiro Faria, G Ariceta, L Sartz, S Bakkaloglu, A Duzova, M Ekim, A Karabay-Bayazit, R Düşünsel, S Çalışkan, H Alpay, M Sinha, D Hothi, R Shroff Nephrology Dialysis Transplantation, 2019
Management of children with congenital nephrotic syndrome: Challenging treatment paradigms Stephanie Dufek, Tuula Holtta, Agnes Trautmann, Elisa Ylinen, Harika Alpay, Gema Ariceta, Christoph Aufricht, Justine Bacchetta, Sevcan A Bakkaloglu, Aysun Bayazit, Rumeysa Yasemin Cicek, Ismail Dursun, Ali Duzova, Mesiha Ekim, Daniela Iancu, Augustina Jankauskiene, Günter Klaus, Fabio Paglialonga, Andrea Pasini, Nikoleta Printza, Valerie Said Conti, Maria do Sameiro Faria, Claus Peter Schmitt, Constantinos J Stefanidis, Enrico Verrina, Enrico Vidal, Karel Vondrak, Hazel Webb, Argyroula Zampetoglou, Detlef Bockenhauer, Alberto Edefonti, Rukshana Shroff Nephrology Dialysis Transplantation, 2019
Haemodiafiltration use in children: data from the Italian Pediatric Dialysis Registry Fabio Paglialonga, Enrico Vidal, Carmine Pecoraro, Isabella Guzzo, Mario Giordano, Bruno Gianoglio, Ciro Corrado, Rosa Roperto, Ilse Ratsch, Salvatore Luzio, Luisa Murer, Silvia Consolo, Giovanni Pieri, Giovanni Montini, Alberto Edefonti, Enrico Verrina Pediatric Nephrology, 2019
Acute dialysis in children: results of a European survey For the ESCAPE Network, Isabella Guzzo, Lara de Galasso, Sevgi Mir, Ipek Kaplan Bulut, Augustina Jankauskiene, Vilmanta Burokiene, Mirjana Cvetkovic, Mirjana Kostic, Aysun Karabay Bayazit, Dincer Yildizdas, Claus Peter Schmitt, Fabio Paglialonga, Giovanni Montini, Ebru Yilmaz, Jun Oh, Lutz Weber, Christina Taylan, Wesley Hayes, Rukshana Shroff, Enrico Vidal, Luisa Murer, Francesca Mencarelli, Andrea Pasini, Ana Teixeira, Alberto Caldas Afonso, Dorota Drozdz, Franz Schaefer, Stefano Picca Journal of Nephrology, 2019
Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry Michael Boehm, Marjolein Bonthuis, Marlies Noordzij, Jérôme Harambat, Jaap W. Groothoff, Ángel Alonso Melgar, Jadranka Buturovic, Ruhan Dusunsel, Marc Fila, Anna Jander, Linda Koster-Kamphuis, Gregor Novljan, Pedro J. Ortega, Fabio Paglialonga, Maria T. Saravo, Constantinos J. Stefanidis, Christoph Aufricht, Kitty J. Jager, Franz Schaefer Pediatric Nephrology, 2019
Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases On behalf of the ESPN Dialysis Working Group, Stephanie Dufek, Elisa Ylinen, Agnes Trautmann, Harika Alpay, Gema Ariceta, Christoph Aufricht, Justine Bacchetta, Sevcan Bakkaloglu, Aysun Bayazit, Salim Caliskan, Maria do Sameiro Faria, Ismail Dursun, Mesiha Ekim, Augustina Jankauskiene, Günter Klaus, Fabio Paglialonga, Andrea Pasini, Nikoleta Printza, Valerie Said Conti, Claus Peter Schmitt, Constantinos Stefanidis, Enrico Verrina, Enrico Vidal, Hazel Webb, Argyroula Zampetoglou, Alberto Edefonti, Tuula Holtta, Rukshana Shroff Pediatric Nephrology, 2019
Uremic toxin concentrations are related to residual kidney function in the pediatric hemodialysis population Evelien Snauwaert, Els Holvoet, Wim Van Biesen, Ann Raes, Griet Glorieux, Johan Vande Walle, Sanne Roels, Raymond Vanholder, Varvara Askiti, Karolis Azukaitis, Aysun Bayazit, Nur Canpolat, Michel Fischbach, Nathalie Godefroid, Saoussen Krid, Mieczyslaw Litwin, Lukasz Obrycki, Fabio Paglialonga, Bruno Ranchin, Charlotte Samaille, Franz Schaefer, Claus Peter Schmitt, Brankica Spasojevic, Constantinos J. Stefanidis, Maria Van Dyck, Koen Van Hoeck, Laure Collard, Sunny Eloot, Rukshana Shroff Toxins, 2019
Effects of hemodiafiltration versus conventional hemodialysis in children with ESKD: The HDF, heart and height study Rukshana Shroff, Colette Smith, Bruno Ranchin, Aysun K. Bayazit, Constantinos J. Stefanidis, Varvara Askiti, Karolis Azukaitis, Nur Canpolat, Ayşe Ağbaş, Helen Aitkenhead, Ali Anarat, Bilal Aoun, Daley Aofolaju, Sevcan Azime Bakkaloglu, Devina Bhowruth, Dagmara Borzych-Dużałka, Ipek Kaplan Bulut, Rainer Büscher, John Deanfield, Claire Dempster, Ali Duzova, Sandra Habbig, Wesley Hayes, Shivram Hegde, Saoussen Krid, Christoph Licht, Mieczyslaw Litwin, Mark Mayes, Sevgi Mir, Rose Nemec, Lukasz Obrycki, Fabio Paglialonga, Stefano Picca, Charlotte Samaille, Mohan Shenoy, Manish D. Sinha, Brankica Spasojevic, Lynsey Stronach, Enrico Vidal, Karel Vondrák, Alev Yilmaz, Ariane Zaloszyc, Michel Fischbach, Claus Peter Schmitt, Franz Schaefer Journal of the American Society of Nephrology, 2019
A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network on behalf of the ItalKid-HUS Network, Gianluigi Ardissino, Francesca Tel, Sara Testa, Fabio Paglialonga, Selena Longhi, Laura Martelli, Silvia Consolo, Damiano Picicco, Antonella Dodaro, Laura Daprai, Rosaria Colombo, Milena Arghittu, Michela Perrone, Giovanna Chidini, Stefano Scalia Catenacci, Isabella Cropanese, Dario Consonni European Journal of Pediatrics, 2018
Bioimpedance spectroscopy imprecisely assesses lean body mass in pediatric dialysis patients Gregorio P. Milani, Jaap W. Groothoff, Federica A. Vianello, Emilio F. Fossali, Fabio Paglialonga, Sivia Consolo, Alberto Edefonti, Dario Consonni, Dewi van Harskamp, Johannes B. van Goudoever, Henk Schierbeek, Carlo Agostoni, Michiel J.S. Oosterveld Journal of Pediatric Gastroenterology and Nutrition, 2018
Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - The HDF, heart and height (3H) study Rukshana Shroff, Aysun Bayazit, Constantinos J. Stefanidis, Varvara Askiti, Karolis Azukaitis, Nur Canpolat, Ayse Agbas, Ali Anarat, Bilal Aoun, Sevcan Bakkaloglu, Devina Bhowruth, Dagmara Borzych-Dużałka, Ipek Kaplan Bulut, Rainer Büscher, Claire Dempster, Ali Duzova, Sandra Habbig, Wesley Hayes, Shivram Hegde, Saoussen Krid, Christoph Licht, Mieczyslaw Litwin, Mark Mayes, Sevgi Mir, Rose Nemec, Lukasz Obrycki, Fabio Paglialonga, Stefano Picca, Bruno Ranchin, Charlotte Samaille, Mohan Shenoy, Manish Sinha, Colette Smith, Brankica Spasojevic, Enrico Vidal, Karel Vondrák, Alev Yilmaz, Ariane Zaloszyc, Michel Fischbach, Franz Schaefer, Claus Peter Schmitt BMC Nephrology, 2018
A propensity-matched comparison of hard outcomes in children on chronic dialysis on behalf of the Italian Registry for Paediatric Chronic Dialysis, Enrico Vidal, Nicholas C. Chesnaye, Fabio Paglialonga, Bruno Minale, Giovanna Leozappa, Mario Giordano, Bruno Gianoglio, Ciro Corrado, Rosa Maria Roperto, Roberto Chimenz, Francesca Mencarelli, Ilse-Maria Ratsch, Luisa Murer, Enrico Verrina European Journal of Pediatrics, 2018
Long-term renal outcome in children with OCRL mutations: Retrospective analysis of a large international cohort Marcin Zaniew, Arend Bökenkamp, Marcin Kołbuc, Claudio La Scola, Federico Baronio, Anna Niemirska, Maria Szczepańska, Julia Bürger, Angela La Manna, Monika Miklaszewska, Anna Rogowska-Kalisz, Jutta Gellermann, Argyroula Zampetoglou, Anna Wasilewska, Magdalena Roszak, Jerzy Moczko, Aleksandra Krzemień, Dariusz Runowski, Grzegorz Siteń, Iga Załuska-Leśniewska, Patrizia Fonduli, Franca Zurrida, Fabio Paglialonga, Zoran Gucev, Dusan Paripovic, Rina Rus, Valerie Said-Conti, Lisa Sartz, Woo Yeong Chung, Se Jin Park, Jung Won Lee, Yong Hoon Park, Yo Han Ahn, Przemysław Sikora, Constantinos J Stefanidis, Velibor Tasic, Martin Konrad, Franca Anglani, Maria Addis, Hae Il Cheong, Michael Ludwig, Detlef Bockenhauer Nephrology Dialysis Transplantation, 2018
Bioimpedance and Fluid Status in Children and Adolescents Treated With Dialysis Gregorio P. Milani, Jaap W. Groothoff, Federica A. Vianello, Emilio F. Fossali, Fabio Paglialonga, Alberto Edefonti, Carlo Agostoni, Dario Consonni, Dewi van Harskamp, Johannes B. van Goudoever, Henk Schierbeek, Michiel J.S. Oosterveld American Journal of Kidney Diseases, 2017
Early volume expansion and outcomes of hemolytic uremic syndrome Gianluigi Ardissino, Francesca Tel, Ilaria Possenti, Sara Testa, Dario Consonni, Fabio Paglialonga, Stefania Salardi, Nicolò Borsa-Ghiringhelli, Patrizia Salice, Silvana Tedeschi, Pierangela Castorina, Rosaria Maria Colombo, Milena Arghittu, Laura Daprai, Alice Monzani, Rosangela Tozzoli, Maurizio Brigotti, Erminio Torresani Pediatrics, 2016
Glomerular pathology in dent disease and its association with kidney function Xiangling Wang, Franca Anglani, Lada Beara-Lasic, Anila J. Mehta, Lisa E. Vaughan, Loren Herrera Hernandez, Andrea Cogal, Steven J. Scheinman, Gema Ariceta, Robert Isom, Lawrence Copelovitch, Felicity T. Enders, Dorella Del Prete, Giuseppe Vezzoli, Fabio Paglialonga, Peter C. Harris, John C. Lieske, on behalf of the Investigators of the Rare Kidney Stone Consortium Clinical Journal of the American Society of Nephrology, 2016
Hemodialysis in children with ventriculoperitoneal shunts: prevalence, management and outcomes on behalf of the European Paediatric Dialysis Working Group, Elizabeth Wright, Michel Fischbach, Ariane Zaloszyc, Fabio Paglialonga, Christoph Aufricht, Stephanie Dufek, Sevcan Bakkaloğlu, Günter Klaus, Aleksandra Zurowska, Mesiha Ekim, Gema Ariceta, Tuula Holtta, Augustina Jankauskiene, Claus Peter Schmitt, Constantinos J. Stefanidis, Johan Vande Walle, Karel Vondrak, Alberto Edefonti, Rukshana Shroff Pediatric Nephrology, 2016
Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome Gianluigi Ardissino, Valeria Daccò, Sara Testa, Cristina Felice Civitillo, Francesca Tel, Ilaria Possenti, Mirco Belingheri, Pierangela Castorina, Nicolò Bolsa-Ghiringhelli, Silvana Tedeschi, Fabio Paglialonga, Stefania Salardi, Dario Consonni, Elena Zoia, Patrizia Salice, Giovanna Chidini Pediatric Nephrology, 2015
Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units Fabio Paglialonga, Claus Peter Schmitt, Rukshana Shroff, Karel Vondrak, Christoph Aufricht, Alan Rees Watson, Gema Ariceta, Michael Fischbach, Gunter Klaus, Tuula Holtta, Sevcan A. Bakkaloglu, Alexandra Zurowska, Augustina Jankauskiene, Johan Vande Walle, Betti Schaefer, Elizabeth Wright, Roy Connell, Alberto Edefonti Pediatric Nephrology, 2015
Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome Maurizio Brigotti, Pier Luigi Tazzari, Elisa Ravanelli, Domenica Carnicelli, Laura Rocchi, Valentina Arfilli, Gaia Scavia, Fabio Minelli, Francesca Ricci, Pasqualepaolo Pagliaro, Alfonso V. S. Ferretti, Carmine Pecoraro, Fabio Paglialonga, Alberto Edefonti, Maria Antonietta Procaccino, Alberto E. Tozzi, Alfredo Caprioli Pediatric Infectious Disease Journal, 2011
Assessment of nutritional status in children with chronic kidney disease Minerva Pediatrica, 2010
